BD MAX CTGCTV2, BD MAX System
FDA 510(k) K182692 · Becton, Dickinson and Company
510(k) numberK182692
Submission
- Device name
- BD MAX CTGCTV2, BD MAX System
- Applicant
- Becton, Dickinson and Company
Sparks, MD, US - Received
- September 27, 2018
- Decision date
- January 8, 2019
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- OUY – Trichomonas Vaginalis Nucleic Acid Amplification Test System
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3860
- Specialty
- Immunology
In vitro nucleic acid amplification test for the qualitative detection of ribosomal rna from trichomonas vaginalis as an aid in the diagnosis of trichomoniasis from vaginal, cervical, urogenital and gynecological specimens from symptomatic patients
Other 510(k)s with product code OUY
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K231316 | Aptima Trichomonas vaginalis AssayOUY · Traditional | Hologic, Inc. | 11/06/2023SE |
| K151589 | BD Max Ct/Gc/Tv, BD Max InstrumentOUY · Traditional | Becton, Dickinson and Company | 09/06/2016SE |
| K161619 | Xpert TV, Xpert Urine Specimen Collection Kit, GeneXpert Dx Systems (GX-I, GX-II, GX-IV…OUY · Traditional | Cepheid | 08/29/2016SE |
| K161182 | Solana Trichomonas AssayOUY · Traditional | Quidel Corporation | 08/15/2016SE |
| K151565 | Xpert® TV Assay on the Cepheid GeneXpert Instrument Systems (GeneXpert Dx, GeneXpert…OUY · Traditional | Cepheid | 10/16/2015SE |
| K143329 | AmpliVue Trichomonas AssayOUY · Traditional | Quidel Corporation | 03/17/2015SE |
| K130268 | BD Probetec Trichomonas Vaginalis (TV) QX Amplified DNA AssayOUY · Traditional | Becton, Dickinson & CO | 08/23/2013SE |
| K122062 | Aptima Trichomonas Vaginalis Assay - PantherOUY · Traditional | Gen-Probe, Inc. | 01/09/2013SE |
More from Gen-Probe, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K260128 | BD Preset and BD A-Line Arterial Blood Collection SyringesJKA · Special | 04/15/2026SE |
| K252506 | BD Vacutainer® Safety-Lok Blood Collection Set; BD Vacutainer® Safety-Lok Blood…JKA · Traditional | 04/10/2026SE |
| K252378 | BD® MiniDraw Capillary Blood Collection System with BD® MiniDraw SST Capillary Blood…JKA · Traditional | 04/10/2026SE |
| K260184 | Onclarity Self-Collection KitSEP · Traditional | 04/02/2026SE |
| K252040 | BD Vacutainer® Plasma Separator Tubes (PST), BD Vacutainer® Sodium Heparin Blood…JKA · Traditional | 03/13/2026SE |
| K250884 | 0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP SyringeNGT · Traditional | 12/02/2025SE |
| K250358 | BD Enteric Bacterial Panel for BD COR System, BD Enteric Bacterial Panel plus for BD COR…PCI · Traditional | 10/31/2025SE |
| K250059 | BD PhaSeal Optima Connecting Set (C83-O); BD PhaSeal Optima Spike Set (C180-O)ONB · Traditional | 09/12/2025SE |
| K251713 | BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL)LON · Traditional | 08/08/2025SE |
| K251350 | BD Plastipak SyringeFMF · Traditional | 07/29/2025SE |
Questions and answers
When was BD MAX CTGCTV2, BD MAX System cleared by the FDA?
BD MAX CTGCTV2, BD MAX System (K182692) received a 510(k) decision of Substantially Equivalent on January 8, 2019, 103 days after the submission was received.
What is the product code of K182692?
The FDA product code is OUY – Trichomonas Vaginalis Nucleic Acid Amplification Test System, a Class II (moderate risk) device regulated under 21 CFR 866.3860.